| Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation L Shan, K Deng, NS Shroff, CM Durand, SA Rabi, HC Yang, H Zhang, ... Immunity 36 (3), 491-501, 2012 | 869 | 2012 |
| Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection R He, S Hou, C Liu, A Zhang, Q Bai, M Han, Y Yang, G Wei, T Shen, ... Nature 537 (7620), 412-416, 2016 | 684 | 2016 |
| Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations K Deng, M Pertea, A Rongvaux, L Wang, CM Durand, G Ghiaur, J Lai, ... Nature 517 (7534), 381-385, 2015 | 592 | 2015 |
| CRISPR-edited stem cells in a patient with HIV and acute lymphocytic leukemia L Xu, J Wang, Y Liu, L Xie, B Su, D Mou, L Wang, T Liu, X Wang, B Zhang, ... New England Journal of Medicine 381 (13), 1240-1247, 2019 | 462 | 2019 |
| Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor X Chen, R Li, Z Pan, C Qian, Y Yang, R You, J Zhao, P Liu, L Gao, Z Li, ... Cellular & molecular immunology 17 (6), 647-649, 2020 | 367 | 2020 |
| Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19 X Chen, Z Pan, S Yue, F Yu, J Zhang, Y Yang, R Li, B Liu, X Yang, L Gao, ... Signal transduction and targeted therapy 5 (1), 180, 2020 | 278 | 2020 |
| Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection L Shan, K Deng, H Gao, S Xing, AA Capoferri, CM Durand, SA Rabi, ... Immunity 47 (4), 766-775. e3, 2017 | 210 | 2017 |
| TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb X Ma, T Yang, Y Luo, L Wu, Y Jiang, Z Song, T Pan, B Liu, G Liu, J Liu, ... eLife 8, e42426, 2019 | 99 | 2019 |
| Efficient Production of Mice from Embryonic Stem Cells Injected into Four‐or Eight‐Cell Embryos by Piezo Micromanipulation J Huang, K Deng, H Wu, Z Liu, Z Chen, S Cao, L Zhou, X Ye, DL Keefe, ... Stem cells 26 (7), 1883-1890, 2008 | 69 | 2008 |
| Two waves of pro-inflammatory factors are released during the influenza A virus (IAV)-driven pulmonary immunopathogenesis J Zhang, J Liu, Y Yuan, F Huang, R Ma, B Luo, Z Xi, T Pan, B Liu, Y Zhang, ... PLoS pathogens 16 (2), e1008334, 2020 | 60 | 2020 |
| Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry Z Li, M Peng, P Chen, C Liu, A Hu, Y Zhang, J Peng, J Liu, Y Li, W Li, ... Cell Metabolism 34 (3), 424-440. e7, 2022 | 50 | 2022 |
| Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade Y Liu, J Cai, W Liu, Y Lin, L Guo, X Liu, Z Qin, C Xu, Y Zhang, X Su, ... Cell Death & Disease 11 (12), 1062, 2020 | 40 | 2020 |
| Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activity Y Cao, Y Li, X Wang, S Liu, Y Zhang, G Liu, S Ye, Y Zheng, J Zhao, X Zhu, ... Immunity 56 (2), 320-335. e9, 2023 | 34 | 2023 |
| Early treatment may not be early enough K Deng, RF Siliciano Nature 512 (7512), 35-36, 2014 | 29 | 2014 |
| Glycopeptide antibiotic teicoplanin inhibits cell entry of SARS-CoV-2 by suppressing the proteolytic activity of cathepsin L F Yu, T Pan, F Huang, R Ying, J Liu, H Fan, J Zhang, W Liu, Y Lin, Y Yuan, ... Frontiers in Microbiology 13, 884034, 2022 | 27 | 2022 |
| A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2 Y Yuan, X Zhang, R Chen, Y Li, B Wu, R Li, F Zou, X Ma, X Wang, Q Chen, ... Cell Reports 38 (3), 2022 | 27 | 2022 |
| USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication T Pan, Z Song, L Wu, G Liu, X Ma, Z Peng, M Zhou, L Liang, B Liu, J Liu, ... Elife 8, e48318, 2019 | 27 | 2019 |
| Development of Receptor Binding Domain (RBD)‐Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS‐CoV‐2 Delta and Other Variants R Chen, X Zhang, Y Yuan, X Deng, B Wu, Z Xi, G Wang, Y Lin, R Li, ... Advanced science 9 (11), 2105378, 2022 | 26 | 2022 |
| A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD X Wang, A Hu, X Chen, Y Zhang, F Yu, S Yue, A Li, J Zhang, Z Pan, ... Signal Transduction and Targeted Therapy 7 (1), 114, 2022 | 23 | 2022 |
| CD161+ CD4+ T Cells Harbor Clonally Expanded Replication-Competent HIV-1 in Antiretroviral Therapy-Suppressed Individuals X Li, Z Liu, Q Li, R Hu, L Zhao, Y Yang, J Zhao, Z Huang, H Gao, L Li, ... mBio 10 (5), e02121-19, 2019 | 23 | 2019 |
Liang ShanWashington University in St. LouisE-mail megerősítve itt: wustl.edu